Antacids Market Size, Share & Trends Analysis Report By Dosage Form (Tablet, Liquid), By Distribution Channel (Retail, Hospital, Online Pharmacy), By Region (APAC, Europe, North America), And Segment Forecasts, 2019 - 2025

Published: Jan, 2019 | Pages: 90 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global antacid market size is expected to reach USD 7.91 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast period. The trend of self-medication for occasional heartburn is one of the major factors driving the market.

Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%.

Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio.

The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.

Further key findings from the report suggest:

• In 2017, tablet segment led the antacid market due to high efficacy compared to other dosage forms. Liquid is anticipated to be the fastest growing segment due to its palatable taste and preferred choice for children and elderly population

• Retail pharmacy led the distribution channel segment due its accessibility and availability. Online pharmacy is anticipated to be the fastest growing segment due to growing adoption of Pharma 3.0 and consumer awareness

• Asia Pacific is estimated to be the largest and fastest growing region over the forecast period due to presence of key players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others

• North America held the second largest market share in 2017 owing to increasing prevalence of different digestive disorders

• Some of the key companies operating in this market are GlaxoSmithKline plc; Bayer AG; Boehringer Ingelheim International GmbH; Dr. Reddy's Laboratories Ltd.; Reckitt Benckiser Group plc; Sun Pharmaceuticals Ltd.; Sanofi; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble.

 Table of Contents

Chapter 1 Methodology And Scope
                 1.1 Research Methodology
                 1.2 Research Scope And Assumptions
                 1.3 List Of Tables

Chapter 2 Executive Summary
                 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
                 3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
                 5.1 Market Variable Analysis
                     5.1.1 Increasing Prevelance Of Gastro Esophageal Reflux Diseases (GERD)
                     5.1.2 Growing Geriatric Population
                     5.1.3 Increasing Prevalence Of Heartburn
                 5.2 Market Restraint Analysis
                     5.2.1 Growing Number Of Alternatives In The Market For Antacids

Chapter 6 Business Environment Analysis
                 6.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                 6.2 Porter's Five Forces Analysis

Chapter 7 Dosage Form Business Analysis
                 7.1 Antacid Market: Dosage Form Movement Analysis
                 7.2 Tablet
                     7.2.1 Tablet Market Estimates And Forecast, 2014 - 2025
                 7.3 Liquid
                     7.3.1 Liquid Market Estimates And Forecast, 2014 - 2025
                 7.4 Others
                     7.4.1 Others Market Estimates And Forecast, 2014 - 2025

Chapter 8 Distribution Channel Business Analysis
                 8.1 Antacid Market: Distribution Channel Movement Analysis
                 8.2 Retail Pharmacy
                     8.2.1 Retail Pharmacy Market Estimates And Forecast, 2014 - 2025
                 8.3 Hospital Pharmacy
                     8.3.1 Hospital Pharmacy Market Estimates And Forecast, 2014 - 2025
                 8.4 Online Pharmacy
                     8.4.1 Online Pharmcay Market Estimates And Forecast, 2014 - 2025

Chapter 9 Regional Business Analysis
                 9.1 Antacid Market: Regional Movement Analysis
                 9.2 North America
                     9.2.1 North America Market Estimates And Forecast, 2014 - 2025
                     9.2.2 U.S.
                         9.2.2.1 U.S. Market Estimates And Forecast, 2014 - 2025
                     9.2.3 Canada
                         9.2.3.1 Canada Market Estimates And Forecast, 2014 - 2025
                 9.3 Europe
                     9.3.1 Europe Market Estimates And Forecast, 2014 - 2025
                     9.3.2 Germany
                     9.3.3 Germany Market Estimates And Forecast, 2014 - 2025
                     9.3.4 U.K.
                     9.3.5 U.K. Market Estimates And Forecast, 2014 - 2025
                 9.4 Asia-Pacific
                     9.4.1 Asia-Pacific Market Estimates And Forecast, 2014 - 2025
                     9.4.2 Japan
                         9.4.2.1 Japan Market Estimates And Forecast, 2014 - 2025
                     9.4.3 China
                         9.4.3.1 China Market Estimates And Forecast, 2014 - 2025
                     9.4.4 India
                         9.4.4.1 India Market Estimates And Forecast, 2014 - 2025
                 9.5 Latin America
                     9.5.1 Latin America Market Estimates And Forecast, 2014 - 2025
                     9.5.2 Brazil
                         9.5.2.1 Brazil Market Estimates And Forecast, 2014 - 2025
                     9.5.3 Mexico
                         9.5.3.1 Market Estimates And Forecast, 2014 - 2025
                 9.6 Middle East And Africa
                     9.6.1 Middle-East And Africa Market Estimates And Forecast, 2014 - 2025
                     9.6.2 South Africa
                     9.6.3 South Africa Market Estimates And Forecast, 2014 - 2025

Chapter 10 Company Profiles
                 10.1 Company Profiles
                     10.1.1 GlaxoSmithkline plc.
                         10.1.1.1 Company Overview
                         10.1.1.2 Financial Performance
                         10.1.1.3 Product Benchmarking
                         10.1.1.4 Strategic Initiatives
                     10.1.2 Bayer AG
                         10.1.2.1 Company Overview
                         10.1.2.2 Financial Performance
                         10.1.2.3 Product Benchmarking
                         10.1.2.4 Strategic Initiatives
                     10.1.3 Pfizer, Inc.
                         10.1.3.1 Company Overview
                         10.1.3.2 Financial Performance
                         10.1.3.3 Product Benchmarking
                         10.1.2.4 Strategic Initiatives
                     10.1.4 Boehringer Ingelheim International GmbH
                         10.1.4.1 Company Overview
                         10.1.4.2 Product Benchmarking
                         10.1.4.3 Strategic Initiatives
                     10.1.5 Dr. Reddy's Laboratories Ltd.
                         10.1.5.1 Company Overview
                         10.1.5.2 Financial Performance
                         10.1.5.3 Product Benchmarking
                         10.1.4.4 Strategic Initiatives
                     10.1.6 Reckitt Benckiser Group plc.
                         10.1.6.1 Company Overview
                         10.1.6.2 Financial Performance
                         10.1.6.3 Product Benchmarking
                         10.1.6.4 Strategic Initiatives
                     10.1.7 Sanofi
                         10.1.7.1 Company Overview
                         10.1.7.2 Product Benchmarking
                         10.1.7.3 Strategic Initiatives
                     10.1.8 Sun Pharmaceuticals Ltd.
                         10.1.8.1 Company Overview
                         10.1.8.2 Financial Performance
                         10.1.8.3 Product Benchmarking
                         10.1.8.4 Strategic Initiatives
                     10.1.9 Takeda Pharmaceutical Company Limited
                         10.1.9.1 Company Overview
                         10.1.9.2 Product Benchmarking
                         10.1.9.3 Strategic Initiatives
                     10.1.10 Procter & Gamble
                         10.1.10.1 Company Overview
                         10.1.10.2 Product Benchmarking
                         10.1.10.3 Strategic Initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 3 North America Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 4 U.S. Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 5 U.S. Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 6 Canada Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 7 Canada Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 8 Europe Antacidmarket, by dosage form 2014 - 2025 (USD Million)
Table 9 Europe Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 10 Germany Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 11 Germany Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 12 U.K. Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 13 U.K. Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 14 Asia Pacific Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 15 Asia Pacific Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 16 Japan Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 17 Japan Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 18 China Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 19 China Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 20 India Antacidmarket, by dosage form 2014 - 2025 (USD Million)
Table 21 India Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 22 Latin America Antacidmarket, by dosage form 2014 - 2025 (USD Million)
Table 23 Latin America Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 24 Brazil Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 25 Brazil Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 26 Mexico Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 27 Mexico Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 28 MEA Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 29 MEA Antacid market, by distribution channel 2014 - 2025 (USD Million)
Table 30 South Africa Antacid market, by dosage form 2014 - 2025 (USD Million)
Table 31 South Africa Antacid market, by distribution channel 2014 - 2025 (USD Million)

List of Figures

Fig. 1 Antacidmarket, 2017
Fig. 2 Antacid market segmentation
Fig. 3 Antacid market driver impact
Fig. 4 Antacid market driver impact
Fig. 5 SWOT Analysis, By Factor (Political & legal economic and technological)
Fig. 6 Porter's Five Forces Analysis
Fig. 6 Antacid market: Dosage form outlook and key takeaways
Fig. 7 Antacid market: Dosage Form Movement Analysis
Fig. 8 Tablet market estimates and forecast, 2014 - 2025
Fig. 9 Liquid market estimates and forecast, 2014 - 2025
Fig. 10 Others market estimates and forecast, 2014 - 2025
Fig. 11 Antacid market: Distribution channel outlook and key takeaways
Fig. 12 Antacid market: Distribution Channel Movement Analysis
Fig. 13 Retail pharmacy market estimates and forecast, 2014 - 2025
Fig. 14 Hospital pharmacy market estimates and forecast, 2014 - 2025
Fig. 15 Online pharmacy market estimates and forecast, 2014 - 2025
Fig. 16 Antacid market: Regional outlook and key takeaways
Fig. 17 Antacid market: Regional movement analysis
Fig. 18 North America
Fig. 19 North America. market estimates and forecast, 2014 - 2025
Fig. 20 U.S. market estimates and forecast, 2014 - 2025
Fig. 21 Canada market estimates and forecast, 2014 - 2025
Fig. 22 Europe
Fig. 23 Europe market estimates and forecast, 2014 - 2025
Fig. 24 Germany market estimates and forecast, 2014 - 2025
Fig. 25 U.K. market estimates and forecast, 2014 - 2025
Fig. 26 Asia-Pacific
Fig. 27 Asia-Pacific market estimates and forecast, 2014 - 2025
Fig. 28 Japan market estimates and forecast, 2014 - 2025
Fig. 29 China market estimates and forecast, 2014 - 2025
Fig. 30 India market estimates and forecast, 2014 - 2025
Fig. 31 Latin America
Fig. 32 Latin America market estimates and forecast, 2014 - 2025
Fig. 33 Brazil market estimates and forecast, 2014 - 2025
Fig. 34 Mexico market estimates and forecast, 2014 - 2025
Fig. 35 Middle East & Africa
Fig. 36 MEA market estimates and forecast, 2014 - 2025
Fig. 37 South Africa market estimates and forecast, 2014 - 2025
Fig. 38 Company profile